Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
| Autor: | van der Helm, L.H., Veeger, N.J.G.M., Kooy, M. van Marwijk, Beeker, A., de Weerdt, O., de Groot, M., Alhan, C., Hoogendoorn, M., Laterveer, L., van de Loosdrecht, A.A., Koedam, J., Vellenga, E., Huls, G. |
|---|---|
| Zdroj: | In Leukemia Research August 2013 37(8):877-882 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect